US Health Experts Vote in Favor of Approving New Obesity Drug

by Sheela Philomena on  February 23, 2012 at 9:52 AM Drug News
  •   Print
  •   Share
  •   Comments
  •  Text 
 US Health Experts Vote in Favor of Approving New Obesity Drug
An advisory panel of health experts to FDA urged approval of a new obesity drug - Qnexa. The panel voted 20-2 that the FDA should allow Qnexa on the market, saying the latest overall benefit-risk assessment supported its approval.

The drug, made by California-based biotech firm Vivus, is the first obesity drug submitted to the FDA in more than a decade.

Qnexa combines two existing drugs, the appetite suppressant phentermine and topiramate, an anti-convulsant that can be used in conjunction with other drugs for weight loss.

The FDA does not have to follow the advice of the advisory panel, though it usually does. A final decision is expected by April 17.

Source-AFP

 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X
  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
Obesity
Complete Medindia Resources
News Categories:  
Kidney Health Center

Drug Related News

» Drug for Irregular Heartbeat Gets Green Signal » Schizophrenia Drug Differentiates Cancer Stem Cells into Less Threatening Cells
» Docs Who Seldom Meet Drug Reps Continue to Prescribe Drugs With FDA “Black Box” Warnings » Revision in Quality Standards for Heparin
» Acne Drug Users At High Risk of Developing Eye Infections » Patients Who Take Antidepressants When in ICU More Likely to Die
» New Tablet Coating Product by Ideal Cures, In Geneva » Prednisolone Benefits Patients With Bell's Palsy
Read More >>